Phasic muscle activity in sleep and clinical features of Parkinson disease

The absence of atonia during rapid eye movement (REM) sleep and dream‐enactment behavior (REM sleep behavior disorder [RBD]) are common features of sleep in the alpha‐synucleinopathies. This study examined this phenomenon quantitatively, using the phasic electromyographic metric (PEM), in relation to clinical features of idiopathic Parkinson disease (PD). Based on previous studies suggesting that RBD may be prognostic for the development of later parkinsonism, we hypothesized that clinical indicators of disease severity and more rapid progression would be related to PEM.

[1]  A. Singleton,et al.  Tremor dominant parkinsonism: Clinical description and LRRK2 mutation screening , 2008, Movement disorders : official journal of the Movement Disorder Society.

[2]  R. Szymusiak,et al.  Sleep-related neuronal discharge in the basal forebrain of cats , 1986, Brain Research.

[3]  Y. Lai,et al.  Neurotoxic lesions at the ventral mesopontine junction change sleep time and muscle activity during sleep: An animal model of motor disorders in sleep , 2008, Neuroscience.

[4]  Geert Mayer,et al.  The REM sleep behavior disorder screening questionnaire—A new diagnostic instrument , 2007, Movement disorders : official journal of the Movement Disorder Society.

[5]  D. Rye,et al.  Inter-rater reliability for identification of REM sleep in Parkinson's disease. , 2000, Sleep.

[6]  J. Friedman,et al.  Testosterone not associated with violent dreams or REM sleep behavior disorder in men with Parkinson's , 2007, Movement disorders : official journal of the Movement Disorder Society.

[7]  Akinori Akaike,et al.  Estradiol protects mesencephalic dopaminergic neurons from oxidative stress‐induced neuronal death , 1998, Journal of neuroscience research.

[8]  S. Noachtar,et al.  Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls. , 2003, Sleep.

[9]  Michael S Okun,et al.  Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study. , 2006, Archives of neurology.

[10]  D. Dluzen,et al.  Estrogen Alters MPTP‐Induced Neurotoxicity in Female Mice: Effects on Striatal Dopamine Concentrations and Release , 1996, Journal of neurochemistry.

[11]  M. W. Mahowald,et al.  REM sleep parasomnias. , 1996, Neurologic clinics.

[12]  Mark W. Mahowald,et al.  Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder , 1996, Neurology.

[13]  D. Dexter,et al.  Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease , 2004, Pharmacology Biochemistry and Behavior.

[14]  J. Santamaria,et al.  Absence of alterations in serum sex hormone levels in idiopathic REM sleep behavior disorder. , 2007, Sleep.

[15]  M. Mahowald,et al.  REM sleep behaviour disorder: an update on a series of 96 patients and a review of the world literature , 1993 .

[16]  D. Paré,et al.  Substantia nigra reticulata neurons during sleep-waking states: relation with ponto-geniculo-occipital waves , 1991, Brain Research.

[17]  José Luis Molinuevo,et al.  Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study , 2006, The Lancet Neurology.

[18]  Joan Santamaria,et al.  Excessive muscle activity increases over time in idiopathic REM sleep behavior disorder. , 2009, Sleep.

[19]  E. Stepanski,et al.  Daytime sleepiness and alertness in patients with Parkinson disease. , 2004, Sleep.

[20]  J. Guérit.  Movement disorders. Neurologic Principles and Practice, R.L. Watts, W.C. Koller. McGraw Hill, New York (1997), 780 , 1999 .

[21]  J. Jankovic,et al.  Modafinil for daytime somnolence in Parkinson’s disease: double blind, placebo controlled parallel trial , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[22]  E. Tolosa,et al.  Relation between subtype of Parkinson's disease and REM sleep behavior disorder. , 2007, Sleep medicine.

[23]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[24]  Houeto Jean-Luc.  [Parkinson's disease]. , 2022, La Revue du praticien.

[25]  S. Fahn.  Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .

[26]  C. Guilleminault,et al.  Atlas and scoring rules , 1993 .

[27]  M W Mahowald,et al.  Chronic behavioral disorders of human REM sleep: a new category of parasomnia. , 1986, Sleep.

[28]  Jacques Montplaisir,et al.  Polysomnographic features of REM sleep behavior disorder , 1992, Neurology.

[29]  M. Mahowald,et al.  Chapter 75 – REM Sleep Parasomnias , 2005 .

[30]  J. Jankovic,et al.  Variable expression of Parkinson's disease , 1990, Neurology.

[31]  R. Postuma,et al.  REM sleep behaviour disorder in Parkinson’s disease is associated with specific motor features , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[32]  R R Young,et al.  Analysis of stereotyped voluntary movements at the elbow in patients with Parkinson's disease. , 1977, Journal of neurology, neurosurgery, and psychiatry.

[33]  Bart Post,et al.  UvA-DARE ( Digital Academic Repository ) Clinimetrics , clinical profile and prognosis in early Parkinson ’ s disease , 2009 .

[34]  B. Boeve,et al.  Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy , 2001, Movement disorders : official journal of the Movement Disorder Society.

[35]  R. Stafford,et al.  Principles and Practice of Sleep Medicine , 2001 .

[36]  H. Devries.  MUSCLES ALIVE-THEIR FUNCTIONS REVEALED BY ELECTROMYOGRAPHY , 1976 .

[37]  D. Lehmann,et al.  MUSCLE TONUS IN HUMAN SUBJECTS DURING SLEEP AND DREAMING. , 1964, Experimental neurology.

[38]  E. Wolters,et al.  Imaging of dopamine transporters with [123I]FP‐CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease , 2001, Synapse.

[39]  Robert A Koeppe,et al.  Validation of a polysomnographic score for REM sleep behavior disorder. , 2005, Sleep.

[40]  Donald L Bliwise,et al.  Quantification of Electromyographic Activity During Sleep: A Phasic Electromyographic Metric , 2006, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[41]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[42]  K. Eguchi,et al.  Characterization of the neurons in the region of solitary tract nucleus during sleep , 1980, Physiology & Behavior.

[43]  Sid Gilman,et al.  EMG variance during polysomnography as an assessment for REM sleep behavior disorder. , 2007, Sleep.

[44]  Donald L Bliwise,et al.  Elevated PEM (phasic electromyographic metric) rates identify rapid eye movement behavior disorder patients on nights without behavioral abnormalities. , 2008, Sleep.

[45]  R. Postuma,et al.  Idiopathic REM sleep behavior disorder in the transition to degenerative disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[46]  M W Mahowald,et al.  Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. , 2007, Brain : a journal of neurology.

[47]  A. Bonnet,et al.  [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.

[48]  B. Boeve,et al.  Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. , 2000, Brain : a journal of neurology.

[49]  M. Okun,et al.  Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson disease. , 2002, Archives of neurology.

[50]  S. Leurgans,et al.  Variability of EMG patterns: A potential neurophysiological marker of Parkinson’s disease? , 2009, Clinical Neurophysiology.